A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients
Status:
Completed
Trial end date:
2018-10-30
Target enrollment:
Participant gender:
Summary
This is a phase 4, randomized, double-blind, multicenter clinical trial to evaluate the
efficacy and safety of YMC026 in respiratory disease patients with cough and sputum as the
main symptoms